These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29072522)

  • 21. Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
    Bohula EA; Scirica BM; Fanola C; Inzucchi SE; Keech A; McGuire DK; Smith SR; Abrahamsen T; Francis BH; Miao W; Perdomo CA; Satlin A; Wiviott SD; Sabatine MS
    Am Heart J; 2018 Aug; 202():39-48. PubMed ID: 29803985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential use of selective 5-HT2C agonists in treating obesity.
    Smith BM; Thomsen WJ; Grottick AJ
    Expert Opin Investig Drugs; 2006 Mar; 15(3):257-66. PubMed ID: 16503763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of Action of Cassiae Semen for Weight Management: A Computational Molecular Docking Study of Serotonin Receptor 5-HT2C.
    Yuen H; Hung A; Yang AWH; Lenon GB
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5-HT
    Campbell EJ; Bonomo Y; Pastor A; Collins L; Norman A; Galettis P; Johnstone J; Lawrence AJ
    Pharmacol Res Perspect; 2021 May; 9(3):e00767. PubMed ID: 33929084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.
    Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ
    Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials.
    Singh AK; Singh R
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):183-190. PubMed ID: 31815555
    [No Abstract]   [Full Text] [Related]  

  • 27. Preclinical evidence for combining the 5-HT
    Fletcher PJ; Li Z; Silenieks LB; MacMillan C; DeLannoy I; Higgins GA
    Addict Biol; 2019 May; 24(3):376-387. PubMed ID: 29498158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2 new drugs for weight loss.
    Med Lett Drugs Ther; 2012 Sep; 54(1398):69-71. PubMed ID: 22992487
    [No Abstract]   [Full Text] [Related]  

  • 29. Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
    Smith BM; Smith JM; Tsai JH; Schultz JA; Gilson CA; Estrada SA; Chen RR; Park DM; Prieto EB; Gallardo CS; Sengupta D; Dosa PI; Covel JA; Ren A; Webb RR; Beeley NR; Martin M; Morgan M; Espitia S; Saldana HR; Bjenning C; Whelan KT; Grottick AJ; Menzaghi F; Thomsen WJ
    J Med Chem; 2008 Jan; 51(2):305-13. PubMed ID: 18095642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.
    Bays HE
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1429-45. PubMed ID: 19900026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour.
    Higgs S; Cooper AJ; Barnes NM
    Psychopharmacology (Berl); 2016 Feb; 233(3):417-24. PubMed ID: 26507195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.
    Gannon BM; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Selective 5-HT
    Silenieks LB; Carroll NK; Van Niekerk A; Van Niekerk E; Taylor C; Upton N; Higgins GA
    ACS Chem Neurosci; 2019 Jul; 10(7):3284-3295. PubMed ID: 31082204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lorcaserin: Worthy of Further Insights? Results from Recent Research.
    Mazza M; Kotzalidis GD; Marano G; De Berardis D; Martinotti G; Romagnoli E; Biondi-Zoccai G; Abbate A; Sani G
    CNS Neurol Disord Drug Targets; 2024; 23(3):278-283. PubMed ID: 37005521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Positive Allosteric Modulator of the Serotonin 5-HT
    García-Cárceles J; Decara JM; Vázquez-Villa H; Rodríguez R; Codesido E; Cruces J; Brea J; Loza MI; Alén F; Botta J; McCormick PJ; Ballesteros JA; Benhamú B; Rodríguez de Fonseca F; López-Rodríguez ML
    J Med Chem; 2017 Dec; 60(23):9575-9584. PubMed ID: 29116785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats.
    De Deurwaerdère P; Ramos M; Bharatiya R; Puginier E; Chagraoui A; Manem J; Cuboni E; Pierucci M; Deidda G; Casarrubea M; Di Giovanni G
    Neuropharmacology; 2020 Apr; 166():107915. PubMed ID: 31862271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.
    Neelakantan H; Holliday ED; Fox RG; Stutz SJ; Comer SD; Haney M; Anastasio NC; Moeller FG; Cunningham KA
    ACS Chem Neurosci; 2017 May; 8(5):1065-1073. PubMed ID: 28107783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT(2C) receptor agonists and the control of appetite.
    Halford JC; Harrold JA
    Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ghrelin's Orexigenic Effect Is Modulated via a Serotonin 2C Receptor Interaction.
    Schellekens H; De Francesco PN; Kandil D; Theeuwes WF; McCarthy T; van Oeffelen WE; Perelló M; Giblin L; Dinan TG; Cryan JF
    ACS Chem Neurosci; 2015 Jul; 6(7):1186-97. PubMed ID: 25727097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.